India, Nov. 2 -- HeartBeam, Inc. (BEAT), a medical technology company focused on detecting and monitoring critical cardiac conditions, announced positive results from its ALIGN-ACS pilot study evaluating its portable 3D ECG system for heart attack assessment.
The HeartBeam System is a portable, cable-free device designed to capture three-dimensional electrical signals from the heart and synthesize them into a 12-lead ECG.
The technology is intended to allow patients to record their own ECGs on demand, including at home, potentially helping physicians remotely assess suspected heart attack symptoms.
In the study, HeartBeam demonstrated higher specificity than standard 12-lead ECG (81.8% vs. 71.4%), with comparable sensitivity (60.2% vs. 6...